S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery

Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F67-9. doi: 10.1136/fn.88.1.f67.

Abstract

Background: Early detection and quantification of brain damage in neonatal asphyxia is important. In adults, S100 protein in blood is associated with damage to the central nervous system.

Objective: To determine whether S100 protein can be detected in arterial and venous cord blood of healthy newborns and to relate S100 protein concentrations in cord blood to mode of delivery.

Method: S100 protein levels in umbilical cord blood of 81 healthy infants were determined.

Results: S100 protein was present in arterial (median concentration 1.62 micro g/l) and venous (median concentration 1.36 micro g/l) cord blood. Levels were significantly higher in vaginal births (median arterial concentration 1.72 micro g/l; median venous concentration 1.48 micro g/l) than births by caesarean section (1.51 micro g/l and 1.26 micro g/l respectively).

Conclusion: More research is necessary to determine whether S100 protein is a useful marker in neonatal asphyxia.

MeSH terms

  • Asphyxia Neonatorum / blood
  • Asphyxia Neonatorum / diagnosis
  • Biomarkers / blood
  • Cesarean Section
  • Delivery, Obstetric / methods*
  • Female
  • Fetal Blood / chemistry*
  • Humans
  • Infant, Newborn
  • Male
  • S100 Proteins / blood*

Substances

  • Biomarkers
  • S100 Proteins